Donor Product
Can a hospital charge for lab tests that are run to test for compatibility, infectious disease or other potential contamination when they receive a donor product (eg stem cells, lymphocyte product, blood product, etc) when the tests have already been performed at the facility where the product was harvested? The hospital receiving the donor product is basically doing their own verification prior to infusing the product. However, can both sets of tests be billed on the recipient’s claim as separate and distinct?
Sign In to comment.